Podcast, Conference Presentation, Fireside Chat, Roundtable
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
- Biogen's Aducanumab is projected to generate a $100 billion market, potentially incentivizing broader company entry into Alzheimer's research and future curative solutions.
- Biogen's approval could establish a precedent for drug approvals based on limited evidence, mirroring a 2016 acting FDA commissioner decision for Duchenne muscular dystrophy that subsequently spurred significant R&D investment.
- The FDA is expected to accelerate drug approval timelines similar to the vaccine process, though a lack of congressional healthcare incentive reform may lead to proliferating approvals and unaffordable costs.
- The pharmaceutical sector may see a rush to approve approximately 10 different Alzheimer's drugs, potentially curing 10% of patients while incurring millions of dollars per person in collective costs, exacerbating inflation.
- Patients with terminal prognoses are expected to continue demanding access to experimental drugs with low downside and high potential upside regardless of cost.
- The US aims to dominate space to counter 100-year plans by Russia and China for satellite ownership and orbital dominance.
- US government funding for private space contracts is predicted to trigger a next industrial age, comparable to the mid-20th century space race's impact on semiconductors and computing.
- Private sector innovation in space is forecast to eventually replace government funding models, following a precedent similar to the Chips Act.
- The space industry risks becoming stifled by heavy regulatory burdens if the current opportunistic moment is not capitalized upon.
- Housing supply may increase aggressively if inflation is confirmed as a temporary "head fake," encouraging builders to green light new projects.
- Populist backlash against hedge fund homeownership could drive societal upheaval, either motivating migration to pro-development states like Texas or forcing restrictive states to relax building regulations.
- Modular home construction utilizing factory methods, akin to Tesla's approach, could reduce construction timelines by six months to a year, shifting primary constraints to state regulatory decisions.
- California faces potential loss of tax revenue and economic growth if homeownership remains inaccessible, as it accounts for 60 to 70% of average American wealth creation.
- The US tax system is trending toward mandatory publication of tax records for large holdings, potentially leading to a minimum or wealth tax.
- Proposed tax rule changes could tax asset gains annually rather than upon sale, creating liquidity issues for owners of long-held assets who have not realized cash appreciation.
- Restrictions on wealth leverage tools like margin loans could impede wealth growth for individuals, contrasting with strategies historically used by figures like Warren Buffett.
- A "Great Reconciliation" is envisioned through the implementation of universal healthcare, unrestricted single-family home construction, and free trade schools.
- Bitcoin is currently facing collapse due to toxicity and cult-like behavior that alienates participants unwilling to engage in aggression.
- Young men frustrated with societal expectations are increasingly finding acceptance in rigid communities like Bitcoin maximalism, potentially discouraging independent thought.
- Companies such as Snowflake are prioritizing high-performance organizational structures over diversity, sparking debate on the coexistence of meritocracy and diversity initiatives.
- Nuclear energy is identified as the fastest path to carbon neutrality and sustainable ecosystems, despite opposition from environmental groups like Greenpeace.
- China's 996 work culture, involving 9 a.m. to 9 p.m. shifts six days a week, poses a competitive threat to the US from a population of 1.2 billion pursuing long-term goals.
- Biotechnology remains a sector of complete US dominance, with losing this lead potentially resulting in the loss of the associated global market.
- Within the next decade or two, it may become feasible to convert human hair cells into stem cells and grow a clone of an individual without fertilization, a process currently only demonstrated in plants.